Search Results

Biorasi, a leading global full-service contract research organization, is proud to announce the achievement of ISO 9001:2015 certification.

Biorasi , a leading global, full-service contract research organization (CRO), is proud to announce the appointment of Jamie P. Dwyer, MD to the position of Scientific Advisory Board (SAB) member.

Biorasi, a leading global full-service contract research organization, is proud to announce the appointment of Alex A. Adjei, MD, PhD, FACP to the position of Scientific Advisory Board member.

Therapeutic Solutions International announced today its Board of Directors has selected Biorasi as the contract research organization (CRO) to run its Pivotal FDA Registration Clinical Trial assessing efficacy of its JadiCell™ Adult Stem Cell Product in patients with advanced COVID-19.

Biorasi, a leading global full-service contract research organization, has announced the appointment of Jimmy El Hokayem, Ph.D., head of the company’s Neurology and Regenerative Medicine Center of Excellence to the Scientific Advisory Board for the Foundation for Angelman Syndrome Therapeutics.

Biorasi , a leading global full-service contract research organization (CRO), is proud to announce the appointment of Robert S. Negrin, MD to the position of Scientific Advisory Board (SAB) member.

Biorasi , a leading global full-service contract research organization (CRO), has been named on the Inc. 5000 list of the fastest-growing private companies for 2020. This prestigious ranking from Inc. magazine distinguishes Biorasi as an industry leader in the health services and clinical trial management industries. “Biorasi is honored to be included in the Inc. 5000 again this year,” said Scott Nenninger, CFO at Biorasi.

Biorasi , a leading global full-service contract research organization (CRO), announced today that they have selected IBM Watson Health (IBM) as a preferred vendor. This relationship with IBM Watson Health expands Biorasi’s capabilities in clinical trial execution and management through IBM’s Clinical Development (ICD) platform – a clinical data management system (CDMS) designed to help bring efficiency and speed to the clinica

Biorasi, a leading global full-service contract research organization (CRO), is proud to announce the appointment of dermatologist Lawrence Green, MD, FAAD to the position of Scientific Advisory Board (SAB) member.

Biorasi, a leading global full-service contract research organization (CRO), is proud to announce the appointment of Ole Isacson, MD, PhD, Professor of Neurology and Neuroscience, to the position of Scientific Advisory Board (SAB) member